The FDA slapped an import ban on the Chinese valsartan maker linked to a global recall—only to make a confusing mistake in announcing the move. As the company’s shares continue to plummet, the agency has now corrected its statement to
read moreAllegations that AbbVie hired nurse “ambassadors” to boost Humira prescriptions have taken a toll on the company’s stock price—and investors aren’t happy. Now, they have more than one chance to try to collect on their losses, thanks to a new
read moreBayer appears to be taking notes from investors and analysts calling for a split-up after its gigantic Monsanto buyout—and amid fears that its pharma business will suffer under its weight. The German company is reportedly considering hiving off its animal
read moreSanofi has struggled to rev up its multiple sclerosis therapy Lemtrada, but some new long-term data presented Wednesday might help it win over doctors and patients. More: Can Sanofi's new long-term Lemtrada data amp up sales in a crowded MS
read moreU.K.-based CDMO Almac is adding to its U.S. operations with a new building at its site in North Carolina where it says it will house 100 new employees. More: CDMO Almac adding 100 employees to its North Carolina site Source:
read moreDublin, Ireland-based biopharma Carrick Therapeutics has licensed exclusive globl rights to develop and commercialise BTG’s targeted ovarian cancer drug BTG945. More: Carrick licenses targeted ovarian cancer drug from BTG Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals